Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
-153.27%
2026 (actual)
ROA
-82.57%
2026 (actual)
Gross Margin
-
Net Margin
-
Total Assets
A$83,587.68K
2026 (actual)
Net Income
-A$69,021.61K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+179.7 pt
Company
ROA
-31.3 pt
Company
Total Assets
-26.2%
Company
Sector average (own scale)
Net Income
-1.7%
Company
Sector average
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for IMUGENE LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.